Search results for "Amy"

showing 10 items of 1486 documents

Usefulness of Oscillations Added to Mechanical In-Exsufflation in Amyotrophic Lateral Sclerosis.

2019

BACKGROUND: Assisted coughing via mechanical in-exsufflation (MI-E) is a first-line treatment for secretion management in patients with amyotrophic lateral sclerosis (ALS) with unassisted CPF METHODS: We conducted a 12-month, prospective, randomized follow-up study of subjects with ALS for whom assisted coughing techniques were indicated. One group was treated with oscillations in addition to MI-E (MI-E+O), and the other group was treated with conventional MI-E. RESULTS: 29 subjects were included in the MI-E group and 27 subjects were included in the MI-E+O group. Five subjects (8.9%) required invasive techniques for secretion management (3 in the MI-E group and 2 in the MI-E+O group, P = .…

Pulmonary and Respiratory MedicineMaleCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineTracheostomyBronchoscopymedicineHumansIn patientProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedAged 80 and overbusiness.industryAmyotrophic Lateral SclerosisInsufflationGeneral MedicineOdds ratioMiddle Agedmedicine.disease030228 respiratory systemCoughAnesthesiaFemaleExsufflationbusinessRespiratory InsufficiencyFollow-Up StudiesRespiratory care
researchProduct

Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.

2015

BACKGROUND: Noninvasive ventilation (NIV) tolerance has been identified as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). Volume control continuous mandatory ventilation (VC-CMV) NIV has been associated with poor tolerance. The aim of this study was to determine the tolerance of subjects with ALS to VC-CMV NIV. METHODS: This was a prospective study involving subjects with ALS who were treated with VC-CMV NIV. Respiratory and functional parameters were recorded when the subjects began ventilatory support. NIV tolerance was evaluated after 3 months. RESULTS: Eighty-seven subjects with ALS were included. After 3 months, 80 subjects (92%) remained tolerant of NIV. …

Pulmonary and Respiratory MedicineMaleNeuromuscular diseaseTime FactorsPeak Expiratory Flow RateCritical Care and Intensive Care MedicineVolume controlContinuous mandatory ventilationForced Expiratory VolumemedicineHumansProspective StudiesRespiratory systemAmyotrophic lateral sclerosisProspective cohort studyAgedNoninvasive Ventilationbusiness.industryAmyotrophic Lateral SclerosisGeneral MedicineMiddle Agedmedicine.diseaseRespiratory failureCoughAnesthesiaNoninvasive ventilationFemalebusinessRespiratory InsufficiencyRespiratory care
researchProduct

Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic late…

2014

BACKGROUND: Acute lower respiratory infections can impair muscle strength in patients with amyotrophic lateral sclerosis (ALS). When associated with an increase in load on the respiratory system, this situation may precipitate hypercapnic respiratory failure in non-ventilated patients with ALS. The aim of this study was to determine whether a clinical or functional parameter can predict the need for noninvasive ventilation (NIV) during an acute respiratory infection for medically stable, non-ventilated patients with ALS. METHODS: This was a prospective study involving all non-ventilated subjects with ALS admitted due to an acute respiratory infection to a respiratory care unit from a tertia…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyNeuromuscular diseaseVital CapacityCritical Care and Intensive Care MedicineSeverity of Illness IndexFEV1/FVC ratioPredictive Value of TestsmedicineOdds RatioHumansProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedNoninvasive VentilationRespiratory tract infectionsbusiness.industryAmyotrophic Lateral SclerosisRespiratory infectionInsufflationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryLogistic ModelsRespiratory failureCoughAnesthesiaFemalebusinessRespiratory InsufficiencyRespiratory careRespiratory care
researchProduct

Home Mechanical Ventilation in Amyotrophic Lateral Sclerosis Patients Is Not Always a Problem

2000

Pulmonary and Respiratory MedicineMechanical ventilationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMasksCritical Care and Intensive Care Medicinemedicine.diseaseHome Care ServicesPositive-Pressure RespirationTracheostomyPhysical medicine and rehabilitationQuality of LifemedicineHumansMotor Neuron DiseaseAmyotrophic lateral sclerosisCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

2012

The objective of this in-vitro study was to determine whether admixtures of the inhalation solutions Pulmozyme(®) (Dornase alfa) and either Bramitob(®) or Tobi(®) (both containing Tobramycin) are physicochemically compatible and to analyze the aerodynamic parameters of these admixtures. After mixing, test solutions were stored at room temperature and under ambient light conditions over a period of 24 h. Tobramycin concentrations were determined by using a fluorescence immunoassay. Stability of dornase alfa was determined by size-exclusion high performance liquid chromatography, ultraviolet spectroscopy, sodium dodecyl sulfate polyacrylamide gel electrophoresis and tentacle strong cation-exc…

Pulmonary and Respiratory MedicineTime FactorsDrug StorageHigh-performance liquid chromatographyDrug Incompatibilitychemistry.chemical_compoundDrug StabilityAdministration InhalationmedicineTobramycinGeometric standard deviationDeoxyribonuclease IPharmacology (medical)Sodium dodecyl sulfateParticle SizeAerosolsChromatographyInhalationNebulizers and VaporizersBiochemistry (medical)Osmolar ConcentrationDornase alfaHydrogen-Ion ConcentrationRecombinant ProteinsAnti-Bacterial AgentsDrug CombinationsPharmaceutical SolutionschemistryCompatibility (mechanics)TobramycinFeasibility StudiesParticle fractionmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Urticaria and bacterial infections

2014

The association between urticaria and infectious diseases has been discussed for >100 years. However, a causal relationship with underlying or precipitating infection is difficult to establish. The purpose of this work was to perform a systematic analysis of the published cases of urticaria associated with bacterial infections. We give an umbrella breakdown of up-to-date systematic reviews and other important publications on the complex association of urticaria and bacterial infections. We did a Medline search, for English language articles published until January 2014, using the key words "urticaria" and "bacteria/bacterial disease"; a second analysis was performed in groups of bacteria an…

Pulmonary and Respiratory MedicineUrticariaPATHOGENESISCHILDRENBrucellaLyme diseaseANGIOEDEMAimmune system diseasesHELICOBACTER-PYLORIMYCOPLASMA-PNEUMONIAE INFECTION; HELICOBACTER-PYLORI; LYME-DISEASE; ANGIOEDEMA; CHILDREN; BRUCELLOSIS; VASCULITIS; MANIFESTATIONS; PATHOGENESIS; EOSINOPHILIAparasitic diseasesHumansImmunology and AllergyMedicineVASCULITISskin and connective tissue diseasesBRUCELLOSISBacterial diseaseChlamydiaEOSINOPHILIAAngioedemabiologybusiness.industryLYME-DISEASEBacterial InfectionsGeneral MedicineHelicobacter pylorimedicine.diseasebiology.organism_classificationMANIFESTATIONSMycoplasma pneumoniaImmunologyMYCOPLASMA-PNEUMONIAE INFECTIONmedicine.symptombusinessPneumonia (non-human)
researchProduct

Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation

2018

There is general agreement that noninvasive ventilation (NIV) prolongs survival in amyotrophic lateral sclerosis (ALS) and that the main cause of NIV failure is the severity of bulbar dysfunction. However, there is no evidence that bulbar impairment is a contraindication for NIV. The aim of this study was to determine the effect of bulbar impairment on survival in ALS patients with NIV. ALS patients for whom NIV was indicated were included. Those patients who refused NIV were taken as the control group. 120 patients who underwent NIV and 20 who refused NIV were included. The NIV group presented longer survival (median 18.50 months, 95% CI 12.62–24.38 months) than the no-NIV group (3.00 mont…

Pulmonary and Respiratory Medicinebusiness.industrylcsh:Rlcsh:MedicineOriginal Articlesmedicine.disease03 medical and health sciences0302 clinical medicineBulbar dysfunction030228 respiratory system18AnesthesiaMedicineNoninvasive ventilationAmyotrophic lateral sclerosisbusinessContraindication030217 neurology & neurosurgeryERJ Open Research
researchProduct

Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis

2019

Upper airway obstruction with decreased central drive (ODCD) is one of the causes of ineffective noninvasive ventilation (NIV) in amyotrophic lateral sclerosis (ALS). The aim of this study is to determine the mechanism responsible for ODCD in ALS patients using NIV. This is a prospective study that included ALS patients with home NIV. Severity of bulbar dysfunction was assessed with the Norris scale bulbar subscore; data on upper or lower bulbar motor neuron predominant dysfunction on physical examination were collected. Polysomnography was performed on every patient while using NIV and the ODCD index (ODCDI: number of ODCD events/total sleep time) was calculated. To determine the possible …

Pulmonary and Respiratory Medicinemedicine.medical_specialty8lcsh:MedicinePolysomnography03 medical and health sciences0302 clinical medicineInternal medicineHyperventilationMedicineAmyotrophic lateral sclerosismedicine.diagnostic_testbusiness.industryUpper motor neuronlcsh:ROriginal Research LetterMotor neuronAirway obstructionmedicine.diseasemedicine.anatomical_structure030228 respiratory systemControl of respirationCardiologymedicine.symptombusinessAirway030217 neurology & neurosurgeryERJ Open Research
researchProduct

Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?

2017

The technology underlying the development of novel ventilatory modes for long-term noninvasive ventilation of patients with chronic hypercapnia is continuously evolving. Volume-targeted pressure-controlled ventilation is a hybrid ventilation mode designed to combine the advantages of conventional ventilation modes, while avoiding their drawbacks. However, manufacturers have created different names and have patented algorithms and set-up variables, which can result in confusion for physicians and respiratory therapists. In addition, clear evidence for the superiority of this novel mode has not yet been established. These factors have most likely hindered more widespread use of this mode in c…

Pulmonary and Respiratory Medicinemedicine.medical_specialtySLEEP QUALITYPressure controlled ventilationChronic hypercapniaHOME MECHANICAL VENTILATIONOBSTRUCTIVE PULMONARY-DISEASEAMYOTROPHIC-LATERAL-SCLEROSISlaw.inventionHypercapnia03 medical and health sciences0302 clinical medicineOBESITY-HYPOVENTILATION SYNDROMElawACUTE RESPIRATORY-FAILUREmedicineCOPDHumansLEAKS030212 general & internal medicineIntensive care medicineRANDOMIZED CROSSOVER TRIALClinical Trials as TopicHybrid ventilationNoninvasive Ventilationbusiness.industryTerm (time)Clinical PracticeSUPPORT NONINVASIVE VENTILATION030228 respiratory systemEvaluation Studies as TopicVentilation (architecture)Noninvasive ventilationbusinessRespiratory InsufficiencyConventional ventilationHumanThe European respiratory journal
researchProduct

Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.

2012

We present an integrated approach to identify and optimize a novel class of γ-secretase modulators (GSMs) with a unique pharmacological profile. Our strategy included (i) virtual screening through application of a recently developed protocol (PhAST), (ii) synthetic chemistry to discover structure–activity relationships, and (iii) detailed in vitro pharmacological characterization. GSMs are promising agents for treatment or prevention of Alzheimer’s disease. They modulate the γ-secretase product spectrum (i.e., amyloid-β (Aβ) peptides of different length) and induce a shift from toxic Aβ42 to shorter Aβ species such as Aβ38 with no or minimal effect on the overall rate of γ-secretase cleavag…

PyridinesPyridonesMolecular Sequence DataPeptideComputational biologyCHO CellsBiochemistryStructure-Activity RelationshipAlzheimer DiseaseCricetinaeAnimalsHumansγ secretaseAmino Acid Sequencechemistry.chemical_classificationVirtual screeningActivity profileAmyloid beta-PeptidesChemistryGeneral MedicineIntegrated approachIn vitroMinimal effectDrug DesignMolecular MedicineAmyloid Precursor Protein SecretasesACS chemical biology
researchProduct